1. 387 A Phase II, multicenter study of the safety and efficacy of LAG525 in combination with spartalizumab in patients with advanced malignancies. (9th November 2020) Authors: Lin, Chia-Chi; Garralda, Elena; Schöffski, Patrick; Hong, David; Siu, Lillian; Martin, Miguel; Maur, Michela; Hui, Rina; Soo, Ross; Chiu, Joanne; Zhang, Tian; Ma, Brigette; Kyi, Chrisann; Tan, Daniel; Cassier, Philippe; Sarantopoulos, John; Weickhardt, Andrew; Carvajal, Rich; Spratlin, Jennifer; ... Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A235 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗